Amedisys (AMED) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Amedisys Reports First Quarter 2021 Financial Results Updates 2021 Guidance
April 28, 2021 4:05 PM EDTBATON ROUGE, La., April 28, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2021.
Three-Month Periods Ended March 31, 2021 and 2020
Net service revenue increased $45.4Â million to $537.1Â million compared to $491.7Â million in 2020.Net income attributable to Amedisys, Inc. of $49.9Â million compared to $31.8Â million in 2020.Net income attributable to Amedisys, Inc. per diluted share of $1.50 compared to $0.96 in 2020.Adjusted Quarterly Results*
Adjusted EBITDA of $78.6Â million compared to $53.3Â million in 2020.Adjusted net income attributable to Amedisys, Inc. of $51.1Â million compared to... More